Torley Helen bought HALO
August 19, 2026 · Form 4 insider transaction
Torley Helen bought 20,000 shares of Halozyme Therapeutics, Inc. at $18.41 per share, a transaction worth $368.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$18.41
Total value
$368.2K
InsiderTorley Helen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 19, 2026
Filing dateAugust 19, 2026
Shares owned after787,780
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on December 3, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2028.